ML-1437

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameML-1437
Drug Alias NameML-1437
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 2 degradersCyclin-dependent kinase 5 degraders
TargetsCyclin-dependent kinase 2Cyclin-dependent kinase 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentre National De La Recherche Scientifique (Cnrs)
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A